Serina Therapeutics Congratulates Juvenescence on $76M Series B
17 Jun 2025 //
GLOBENEWSWIRE
Juvenescence acquires AI drug discovery company Ro5 to boost R&D
05 Jun 2025 //
GLOBENEWSWIRE
Juvenescence Raises $76M In Series B-1 Round Led By M42
21 May 2025 //
GLOBENEWSWIRE
JUVENESCENCE Appoints Dr Richard Marshall CBE as CEO
16 Jan 2023 //
BUSINESSWIRE
Juvenescence, The Buck Institute for Research on Aging launch Selah Therapeutics
11 May 2022 //
PRNEWSWIRE
Juvenescence Announces Licensing Agreement with Evgen Pharma plc
15 Sep 2020 //
BUSINESSNEWS WIRE